Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egesta Lopci

Showing results (31-40 of 198) with videos related to

Pageof 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2025
Metabolic Tumor Volume and Immunotherapy in NSCLC-LetterNicolas Aide, Egesta Lopci, Laurent Dercle
European Journal of Nuclear Medicine and Molecular Imaging|March 14, 2018
Is it time to change our vision of tumor metabolism prior to immunotherapy?Fabio Grizzi, Angelo Castello, Egesta Lopci
Nuclear Medicine and Molecular Imaging|August 23, 2021
Mismatched Imaging Findings of Prostate Cancer Diagnosis: 68 Ga-PSMA PET/CT vs mpMRIEgesta Lopci, Piergiuseppe Colombo, Massimo Lazzeri
Radiology|April 19, 2018
<sup>68</sup>Ga Prostate-specific Membrane Antigen PET/CT for Primary Diagnosis of Prostate Cancer: Complementary or Alternative to Multiparametric MR ImagingEgesta Lopci, Giorgio Guazzoni, Massimo Lazzeri
Nuclear Medicine Review. Central & Eastern Europe|August 12, 2020
Multimodality imaging of ectopic focus in Graves' DiseaseEgesta Lopci, Angelo Castello, Emanuela Mazziotti
European Journal of Nuclear Medicine and Molecular Imaging|January 31, 2020
Evaluating response to immunotherapy with <sup>18</sup>F-FDG PET/CT: where do we stand?Nicolas Aide, Michel De Pontdeville, Egesta Lopci
Frontiers in Immunology|December 25, 2025
Editorial: Enhancing CAR T-cell therapy with imagingEgesta Lopci, Dorine de Jong, Laurent Dercle
Journal of Clinical Medicine|April 3, 2021
Impact of Antibiotic Therapy and Metabolic Parameters in Non-Small Cell Lung Cancer Patients Receiving Checkpoint InhibitorsAngelo Castello, Sabrina Rossi, Luca Toschi, et al.
Clinical Nuclear Medicine|January 22, 2013
Cardiac and acoustic metastases in relapsing melanomaEgesta Lopci, Lorenzo Monti, Luca Balzarini, et al.
Immunotherapy|July 17, 2018
Immunotherapy in non-small-cell lung cancer: potential predictors of response and new strategies to assess activitySabrina Rossi, Angelo Castello, Luca Toschi, et al.
Pageof 20

Showing results (31-40 of 198) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2025
Metabolic Tumor Volume and Immunotherapy in NSCLC-LetterNicolas Aide, Egesta Lopci, Laurent Dercle
European Journal of Nuclear Medicine and Molecular Imaging|March 14, 2018
Is it time to change our vision of tumor metabolism prior to immunotherapy?Fabio Grizzi, Angelo Castello, Egesta Lopci
Nuclear Medicine and Molecular Imaging|August 23, 2021
Mismatched Imaging Findings of Prostate Cancer Diagnosis: 68 Ga-PSMA PET/CT vs mpMRIEgesta Lopci, Piergiuseppe Colombo, Massimo Lazzeri
Radiology|April 19, 2018
<sup>68</sup>Ga Prostate-specific Membrane Antigen PET/CT for Primary Diagnosis of Prostate Cancer: Complementary or Alternative to Multiparametric MR ImagingEgesta Lopci, Giorgio Guazzoni, Massimo Lazzeri
Nuclear Medicine Review. Central & Eastern Europe|August 12, 2020
Multimodality imaging of ectopic focus in Graves' DiseaseEgesta Lopci, Angelo Castello, Emanuela Mazziotti
European Journal of Nuclear Medicine and Molecular Imaging|January 31, 2020
Evaluating response to immunotherapy with <sup>18</sup>F-FDG PET/CT: where do we stand?Nicolas Aide, Michel De Pontdeville, Egesta Lopci
Frontiers in Immunology|December 25, 2025
Editorial: Enhancing CAR T-cell therapy with imagingEgesta Lopci, Dorine de Jong, Laurent Dercle
Journal of Clinical Medicine|April 3, 2021
Impact of Antibiotic Therapy and Metabolic Parameters in Non-Small Cell Lung Cancer Patients Receiving Checkpoint InhibitorsAngelo Castello, Sabrina Rossi, Luca Toschi, et al.
Clinical Nuclear Medicine|January 22, 2013
Cardiac and acoustic metastases in relapsing melanomaEgesta Lopci, Lorenzo Monti, Luca Balzarini, et al.
Immunotherapy|July 17, 2018
Immunotherapy in non-small-cell lung cancer: potential predictors of response and new strategies to assess activitySabrina Rossi, Angelo Castello, Luca Toschi, et al.
Pageof 20